Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Expansion & Characterization of Human Limbus-derived Stromal/mesenchymal Stem Cells in Xeno-free Medium for Therapeutic Applications

April 2023 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Immunomodulation, Tissue Engineering

Rapid & Live-Cell Detection of Senescence in Mesenchymal Stem Cells By Micro Magnetic Resonance Relaxometry

March 2023 Bioprinting, Bioprocessing, Cell Therapy, Immunomodulation, Orthopedic, Tissue Engineering

Evaluation of the Effect of tofacitinib on Bone & Adipose Tissue in Rheumatoid Arthritis

March 2023 Bioprinting, Bioprocessing, Cardiovascular, Clinical, Immunomodulation, Orthopedic, Tissue Engineering

3D Microcapsules for Human Bone Marrow Derived Mesenchymal Stem Cell Biomanufacturing in a Vertical-Wheel Bioreactor

February 2023 Bioprinting, Bioprocessing, Gene Editing, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Development & Characterization of Factor Xa-responsive Materials for Applications in Cell Culture & Biologics Delivery

February 2023 Bioprinting, Bioprocessing, Cell Therapy, Immunomodulation, MedTech, Devices, & Materials, Tissue Engineering

An Effective Peptide-Based Platform for Efficient Exosomal Loading & Cellular Delivery of a MicroRNA

January 2023 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Exosomes / Extracellular Vesicles, Gene Editing, Immunomodulation, Tissue Engineering

Metabolic Phenotype Preservation & Suitability of Hu-man Mesenchymal Stem Cells Cultivated in Stirred Tank Bioreactors for Cell Therapy Applications

January 2023 Bioprinting, Bioprocessing, Cell Therapy, Immunomodulation, Tissue Engineering

Crosslinker Structure Modulates Bulk Mechanical Properties & Dictates hMSC Behavior on Hyaluronic Acid Hydrogels

November 2022 Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, MedTech, Devices, & Materials

Amnion & Chorion Matrix Maintain hMSC Osteogenic Response & Enhance Immunomodulatory & Angiogenic Potential in a Mineralized Collagen Scaffold

November 2022 Immunomodulation

Lentiviral Overexpression of VEGFC in transplanted MSCs Leads to Resolution of Swelling in a Mouse Tail Lymphedema Model

November 2022 Bioprinting, Cancer, Cardiovascular, Cell Therapy, Gene Editing, Immunomodulation, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email